Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Arthur Klausner to speak at "NC Early-Stage Breakfast" in Raleigh, NC.
News | 11. 14. 2007
